Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: A naturalistic controlled 10-year follow-up study

American Journal of Psychiatry

Volumn 165, Issue 5, 2008, Pages 597-603

  Biederman, Joseph ^a   Monuteaux, Michael C ^a   Spencer, Thomas ^a   Wilens, Timothy E ^a   MacPherson, Heather A ^a   Faraone, Stephen V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; GLUE; OPIATE; PSYCHEDELIC AGENT; SEDATIVE AGENT; STEROID;

ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; CONDUCT DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ABUSE; DRUG DEPENDENCE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK; SUBSTANCE ABUSE; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 43949094146     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07091486     Document Type: Article

References (31)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Publishing, 1994
2. Faraone SV, Sergeant J, Gillberg C, Biederman J: The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003; 2:104-113
3. Mannuzza S, Klein RG, Bessler A, Malloy P, Hynes ME: Educational and occupational outcome of hyperactive boys grown up. J Am Acad Child Adolesc Psychiatry 1997; 36:1222-1227
4. Mannuzza S, Klein R, Bessler A, Malloy P, LaPadula M: Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998; 155:493-498
5. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, Wilens TE, Frazier E, Johnson MA: Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002; 159:36-42
6. Biederman J, Monuteaux M, Mick E, Spencer T, Wilens T, Silva J, Snyder L, Faraone SV: Young adult outcome of attention deficit hyperactivity disorder: a controlled 10 year prospective follow-up study. Psychol Med 2006; 36:167-179
7. Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993; 18:247-291
8. Lambert NM, McLeod M, Schenk S: Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse. Addiction 2006; 101:713-725
9. Lambert NM: Stimulant treatment as a risk factor for nicotine and substance abuse, in Attention Deficit Hyperactivity Disorder: State of the Science, Best Practices. Edited by Jensen PS, Cooper J. Kingston, NJ, Civic Research Institute, 2002, pp 1-24
10. Lambert NM: Stimulant treatment as a risk factor for nicotine use and substance abuse, in NIH Consensus Development Conference Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. Bethesda, Md, NIH, 1998, pp 191-198
11. Paternite CE, Loney J, Salisbury H, Whaley MA: Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacol 1999; 9:169-184
12. Barkley RA, Fischer M, Smallish L, Fletcher K: Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse?: A 13-year prospective study. Pediatrics 2003; 111:97-109
13. Mannuzza S, Klein RG, Moulton JL: Does stimulant treatment place children at risk for adult substance abuse?: A controlled, prospective follow-up study. J Child Adolesc Psychopharmacology 2003; 13:273-282
14. Katusic SK, Barbaresi WJ, Colligan RC, Weaver AL, Leibson CL, Jacobsen SJ: Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 2005; 15:764-776
15. Faraone SV, Biederman J, Wilens TE, Adamson JJ: A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults. Psychological Med 2007; 37:1743-1752
16. Wilens T, Faraone SV, Biederman J, Gunawardene S: Does stimulant therapy of attention deficit hyperactivity disorder beget later substance abuse?: A meta-analytic review of the literature. Pediatrics 2003; 111:179-185
17. Faraone SV, Wilens T: Does stimulant treatment lead to substance use disorders? J Clin Psychiatry 2003; 64(suppl 11):9-13
18. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV: Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104:e20
19. Whalen CK, Jamner LD, Henker B, Gehricke JG, King PS: Is there a link between adolescent cigarette smoking and pharmacotherapy for ADHD? Psychol Addict Behav 2003; 17:332-335
20. Fischer M, Barkley RA: Childhood stimulant treatment and risk for later substance abuse. J Clin Psychiatry 2003; 64(suppl)11:19-23
21. Biederman J, Faraone SV, Keenan K, Benjamin J, Krifcher B, Moore C, Sprich-Buckminster S, Ugaglia K, Jellinek MS, Steingard R, Spencer T, Norman D, Kolodny R, Kraus I, Perrin J, Keller MB, Tsuang MT: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder: patterns of comorbidity in probands and relatives in psychiatrically and pediatrically referred samples. Arch Gen Psychiatry 1992; 49:728-738
22. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L, Mennin D, Marrs A, Ouellette C, Moore P, Spencer T, Norman D, Wilens T, Kraus I, Perrin J: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 1996; 53:437-446
23. Busch B, Biederman J, Cohen L, Faraone S, Sayer J, Monuteaux M, Mick E, Zallen B: Similar correlates of ADHD in children from pediatric and psychiatric clinics. Psychiatr Serv 2002; 53:1103-1111
24. Faraone SV, Tsuang MT, Tsuang D: Genetics and Mental Disorders: A Guide for Students, Clinicians, and Researchers. New York, Guilford, 1999
25. Faraone S, Tsuang M: Measuring diagnostic accuracy in the absence of a "gold standard." Am J Psychiatry 1994; 151:650-657
26. Orvaschel H: Schedule for Affective Disorder and Schizophrenia for School-Age Children, Epidemiologic Version. Ft. Lauderdale, Fla, Nova Southeastern University, Center for Psychological Studies, 1994
27. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders. Washington, DC, American Psychiatric Publishing, 1997
28. Hollingshead AB: Four Factor Index of Social Status. New Haven, Conn, Yale University Press, 1975
29. Hintze JL: PASS (Power Analysis and Sample Size System). Kaysville, Utah, NCSS, 2005
30. Lambert NM, Hartsough CS: Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 1998; 31:533-544
31. Biederman J, Faraone SV, Weber W, Russell RL, Rater M, Park K: Correspondence between DSM-III-R and DSM-IV attention deficit hyperactivity disorder (ADHD). J Am Acad Child Adolesc Psychiatry 1997; 36:1682-1687